All Stories

  1. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  2. Public Space and Solid Waste Facilities in Makkah
  3. Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: successful targets against some infectious diseases
  4. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  5. Quantitation of Ciprofloxacin by RP-HPLC from Active and Dosage Formulations
  6. Preparation and antibacterial activities of metal complexes of norfloxacin
  7. Environmental and economic sustainability in the Hajj system
  8. Semicarbazones, thiosemicarbazone, thiazole and oxazole analogues as monoamine oxidase inhibitors: Synthesis, characterization, biological evaluation, molecular docking, and kinetic studies
  9. Multiplex NanoSPR Molecular Biosensor for Blood Cytokine Monitoring
  10. Emulgel: an effective drug delivery system
  11. Synthesis, characterization, and antibacterial studies of pipemidic acid metal complexes
  12. Application of RP-HPLC method for the simultaneous determination of cetirizine in the presence of quinolones
  13. Relative assessment of different statistical instruments and measures for the prediction of promising outcomes using docking, virtual screening and ADMET analysis against HIV-RT
  14. Green chemistry approach: method development and validation for identification and quantification of entecavir using FT-IR in bulk and pharmaceutical dosage form
  15. Green synthesis and characterization of silver-entecavir nanoparticles with stability determination
  16. Simultaneous Determination of Chloroquine and Pyrimethamine with Cetirizine in an Active Form and Human Serum by RP-HPLC
  17. An overview of viruses discovered over the last decades and drug development for the current pandemic
  18. Synthesis and Antiproliferative Activity of 4β‐ O ‐Substituted, 4β‐ N ‐Substituted Deoxypodophyllotoxin Derivatives, and 4β‐ O H‐ 4’‐ O ‐Substituted Podophy...
  19. Bilayer tablets: A developing novel drug delivery system
  20. UV Spectroscopic Method for Optimization and Determination of Glibenclamide in Bulk, Pharmaceutical Dosage Form and its Application for In Vitro Interaction Studies
  21. Possible role of grape fruit in controlling hyperglycemia and associated complications: Better glycemic control in healthy subjects through fruits fibers as compared to fruit juices
  22. Quantitative Analysis of Pantoprazole Sodium Sesquihydrate in Bulk and Solid Dosage Form via UV-Spectrophotometric Method
  23. Using computational docking and virtual screening techniques the characterization of the Trypanosoma brucei pteridine reductase active-site
  24. Synthesis and antibacterial studies of ciprofloxacin-metal complexes
  25. Advancement in the development of heterocyclic nucleosides for the treatment of cancer - A review
  26. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
  27. Preparation and biological evaluation of metronidazole derivatives with monoterpenes and eugenol
  28. QSAR and docking studies on piperidyl-cyclohexylurea derivatives for prediction of selective and potent inhibitor of matriptase
  29. HPLC-UV method for simultaneous determination of irbesartan, candesartan, gliquidone and pioglitazone in formulations and in human serum
  30. Spectrophotometric Method for Determination of Meclizine in Pure and Dosage form Via Ion Pair Complex Formation Using Eosin Y
  31. Reprofiling of full-length phosphonated carbocyclic 2′-oxa-3′-aza-nucleosides toward antiproliferative agents: Synthesis, antiproliferative activity, and molecular docking study
  32. Identification of potent virtual leads and ADME prediction of isoxazolidine podophyllotoxin derivatives as topoisomerase II and tubulin inhibitors
  33. HPLC method development, validation and its application to investigate in vitro effect of pioglitazone on the availability of H1 receptor antagonists
  34. A Novel Quantitative Spectrophotometric Method for the Analysis of Vigabatrin in Pure Form and in Pharmaceutical Formulation
  35. Stability-indicating HPLC-DAD Method for Simultaneous Determination of Atorvastatin, Irbesartan, and Amlodipine in Bulk and Pharmaceutical Preparations
  36. Method Development and Validation of Amlodipine, Gliquidone and Pioglitazone: Application in the Analysis of Human Serum
  37. Fabrication and characterization of doxorubicin functionalized PSS coated gold nanorod
  38. A novel drug delivery system of gold nanorods with doxorubicin and study of drug release by single molecule spectroscopy
  39. Nanomedicine and drug delivery: a mini review
  40. Simultaneous determination of antihistamine anti-allergic drugs, cetirizine, domperidone, chlorphenamine maleate, loratadine, meclizine and buclizine in pharmaceutical formulations, human serum and pharmacokinetics application
  41. Analysis of metformin, glimepiride and pioglitazone in human serum and its application to pharmacokinetics
  42. RP-LC Method for the Simultaneous Determination of Gliquidone, Pioglitazone Hydrochloride, and Atorvastatin in Formulations and Human Serum
  43. A versatile approach for the functionalization of gold nanorods and nanoparticles
  44. Determination of Tryptophan in Raw Materials, Rat Brain and Human Plasma by RP-HPLC Technique
  45. Spectroscopic study to characterize in vitro interaction of losartan with gliquidone and pioglitazone
  46. Physical and chemical characterization of mefenamic acid in different pharmaceutical dosage forms and their stability studies using novel RP-HPLC method
  47. Preparation and characterization of doxorubicin functionalized gold nanoparticles
  48. Simultaneous Determination of Gliquidone, Pioglitazone Hydrochloride, and Verapamil in Formulation and Human Serum by RP-HPLC
  49. Synthesis, characterization and biological activities of cetirizine analogues
  50. High‐performance Liquid Chromatographic Analysis of Pioglitazone, Gliquidone, Rosuvastatin and Simvastatin in Formulations and Human Serum
  51. Simultaneous Determination of Piracetam and its Four Impurities by RP-HPLC with UV Detection
  52. Spectrophotometric determination of gabapentin in pharmaceutical formulations using ninhydrin and π-acceptors
  53. VALIDATED RP-HPLC METHOD FOR QUANTITATION OF GLIQUIDONE IN PHARMACEUTICAL FORMULATION AND HUMAN SERUM
  54. Simultaneous Determination of Gliquidone, Fexofenadine, Buclizine, and Levocetirizine in Dosage Formulation and Human Serum by RP-HPLC
  55. Optimization of quantitative analysis of buclizine hydrochloride using UV spectrophotometry in bulk drug and dosage formulations
  56. Facile and manifest spectrophotometric methods for the determination of six quinolone antibiotics in pharmaceutical formulations using iron salts
  57. Drug interaction studies of gliquidone with fexofenadine, cetirizine, and levocetirizine
  58. Simultaneous Determination of Tranexamic Acid and Losartan Potassium in Dosage Formulations and Human Serum by RP-LC
  59. Preparation and spectroscopic characterization of metal complexes of gliquidone
  60. Drug interaction studies of H2-receptor antagonists with mefloquine, pyrimethamine and sulfadoxine
  61. Spectrophotometric techniques to determine tranexamic acid: Kinetic studies using ninhydrin and direct measuring using ferric chloride